Small caps round-up: TEG, Deltex, Ultrasis
Loss-making green technology company TEG Group has entered into a further contract with recycling firm Viridor to process additional volumes of green and food waste in TEG's network of facilities. The contract will run until April 2014. The revenue over the term of the contract will depend upon the volume of waste delivered by Viridor over the period.
Loss-making green technology company TEG Group has entered into a further contract with recycling firm Viridor to process additional volumes of green and food waste in TEG's network of facilities. The contract will run until April 2014. The revenue over the term of the contract will depend upon the volume of waste delivered by Viridor over the period.
Deltex Medical, the oesophageal Doppler monitor maker, is to raise in the region of £1.5m through a placing of 6.1m new shares at 26p each. The company said it is expecting an increase in orders which will require an increase in working capital, hence the fund raising. The group added that UK surgical probe sales in the first quarter were up 40% year-on-year, a significant increase over both the compound annual growth rate of 20% since the launch of surgical probes in 2004 and the 16% increase in UK surgical probe sales achieved in 2011 compared to 2010. The UK surgical installed base increased by 38 monitors to 557 by March 31st 2012. Sales of probes in export markets in the first quarter were also ahead of 2011, driven by increased uptake in several of Deltex's larger export markets.
Interactive healthcare company Ultrasis has been hit hard by the spending slow-down in the National Health Service (NHS) and may need to take advantage of its own 'Beating the Blues' anxiety programme. Revenue in the six months to the end of January slumped to £0.51m from £1.44m at the interim stage the year before. The company slipped into the red, posting a loss before tax of £0.77m versus a profit the year before of £0.19m. Cash reserves are dwindling fast, and stood at £1.42m at the end of January 2012 versus £2.12m a year earlier. "The current structural reorganisation in the NHS has resulted in a pause in revenue but when the new structures, which are designed to focus on efficient deployment of resources, are fully operational we believe that the cost effective solution that 'Beating the Blues' offers will have direct economic relevance to our NHS customer," the company said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
'We face a £6m inheritance tax bill under Reeves's changes – it's sheer terror'
Thousands of families fear they’ll have no option but to look at selling their firms in a fire sale to pay inheritance tax bills, due to Rachel Reeves’s changes to business property relief
-
Millions of over 50s fear pension investment risk – how should you position your portfolio?
To de-risk or not to de-risk, that is the question. Act too late and you could face irreversible losses. Move too early and miss out on significant gains that could transform your retirement.